Market Research Reports

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

85pages
Published Date: 2014-07-01
 

Description



U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. This research report explains various advancements occurring in this market and analyzes the global regenerative medicine (bone and joint) market by technology and application as well as geographic region. The regenerative medicine (bone and joint) market report comprises an elaborate executive summary, which includes market snapshot that provides overall information of various segments and sub-segments that are contained in the report. Comparative analysis has also been included in the executive summary that resembles the percentage market share of each region (North America, Europe, Asia-Pacific, RoW) in 2012 and 2019 respectively.  

The global market for regenerative medicine is segmented based on technology into stem cell therapy, biomaterials and tissue engineering. The market for these technologies has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the technologies. The market size and forecast in terms of USD million for each technology type has been provided for the period 2011 to 2019. The report on the regenerative medicine (bone and joint) market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application into bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. The market for these applications of regenerative medicine (bone and joint) has been extensively analyzed based on surgeries performed, sales revenue of the required devices and their geographic distribution. The market size and forecast in terms of USD million for each application has been provided for the period 2011 to 2019. The report on the regenerative medicine (bone and joint) market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

Market size estimations involved in-depth study of demand of regenerative medicine bone and joint products in hospitals, clinics and research organizations and average price range of each segment. Additionally, disease prevalence, geographic presence and historical year-on-year growth has been taken into consideration for calculating the market size. The market size estimated for each category is based on secondary data obtained for all the above factors cumulatively. The data obtained from secondary research was analyzed extensively and has been validated with the help of industry experts in order to arrive at the most accurate market size estimations. 

Geographically, the regenerative medicine (bone and joint) market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global regenerative medicine (bone and joint) market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key players’ market share analysis in 2012 in the regenerative medicine market for bone and joint applications. 

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report also profiles major players in the regenerative medicine (bone and joint) market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Inc., Smith & Nephew PLC, Stryker Corporation and Zimmer Holdings, Inc. 

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology
  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
Regenerative Medicine (Bone and Joint) Market, by Application
  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others
Regenerative Medicine (Bone and Joint) Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents



Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 
2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 
2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products
      3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products
      3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market
3.3 Restraints
      3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market
      3.3.2 Ethical issues and post implantation infections are hindering overall market growth
3.4 Opportunities
      3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific
3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market
      3.5.1 Bargaining power of suppliers
      3.5.2 Bargaining power of buyers
      3.5.3 Threat of new entrants
      3.5.4 Threat of substitutes
      3.5.5 Competitive rivalry
3.6 Competitive Landscape
      3.6.1 Market Share Analysis by Key Players, 2012 (Value %)
3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology
4.1 Introduction
      4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 
4.2 Stem Cell Therapy
      4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 
4.3 Biomaterials
      4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 
4.4 Tissue Engineering
      4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications
5.1 Overview
      5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 
5.2 Bone Graft Substitutes
      5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 
5.3 Osteoarticular Diseases
      5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 
5.4 Allogeneic Bones
      5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 
5.5 Autogenic Bones
      5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 
5.6 Others
      5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography
6.1 Overview
      6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 
6.2 North America
      6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
6.3 Europe
      6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
6.5 Rest of the World (RoW) 
      6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

Chapter 7 Recommendations
7.1 Market Strategy for Success
      7.1.1 Rigorous research and development initiatives for innovative products
      7.1.2 Investing in emerging economies
7.2 Barriers and Future Assumptions
      7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth

Chapter 8 Company Profiles
8.1 Anika Therapeutics, Inc. 
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Arthrex, Inc. 
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Baxter International, Inc. 
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 CONMED Corporation
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 DePuy Synthes, Inc. 
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Medtronic, Inc. 
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Smith & Nephew plc
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Stryker Corporation
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Zimmer Holdings, Inc. 
      8.9.1 Business Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments

List of Figures

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation
FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 
FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market
FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)
FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)
FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 
FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 
FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 
FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) 
FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) 

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 
TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 
TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 
TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

Enquiry Before Buying


Free Market Analysis


Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint). However, factors such as stringent regulatory compliance, ethical issues pertaining to stem cell therapy and post implantation rejection are expected to hinder the global market growth during the forecast period. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019. 

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. Moreover, tissue engineering is expected to grow at the highest CAGR during the forecast period. 

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. Autogenic bone application segment is expected to grow at the highest CAGR during the forecast period 2013 to 2019.  

North America was the largest market for regenerative medicine bone and joint application in 2012, accounting for largest market share of the total regenerative medicine (bone and joint) market. The regenerative medicine market in North America witnessed significant growth due to increasing demand of bone and joint reconstructive surgeries. Moreover, favorable government initiatives have also supported the growth of the regenerative medicine bone and joint application market in this region. European market was the second largest of the global market in 2012. Rising geriatric population in European Union is one of the major market drivers in this region as the geriatric group is more prone to suffer from arthritis. Moreover, extensive support and funding provided by European government for regenerative medicine would further accentuate the market growth in this region. 
  
Asia-Pacific was observed to be a promising market for regenerative medicine bone and joint application during the study period owing to the demand of bone graft substitute in this region. This region is considered as an emerging market and is estimated to grow at the highest CAGR from 2013 to 2019. Manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for regenerative medicine bone and joint application. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. In terms of key players the global regenerative medicine bone and joint application market is highly fragmented that comprises of DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute) and Zimmer Holdings, Inc (CopiOs Bone Void Filler). 

regenerative-medicine-market

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research